Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INBRX-106 |
Trade Name | |
Synonyms | INBRX106|INBRX 106|ES 102|ES-102|ES102 |
Drug Descriptions |
INBRX-106 (ES 102) is a hexavalent antibody that binds to the TNFRSF4 (OX40) receptor, resulting in clustering and activation of TNFRSF4 (OX40), and potentially leading to activation of immune response and tumor cell killing (NCI Drug Dictionary). |
DrugClasses | OX40 Antibody 14 |
CAS Registry Number | NA |
NCIT ID | C173983 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
INBRX-106 | INBRX-106 | 0 | 1 |
INBRX-106 + Pembrolizumab | INBRX-106 Pembrolizumab | 0 | 3 |